Karim is dedicated to driving the company's vision of revolutionizing healthcare by equipping clinicians with the transformative power of odor-based screening and diagnostics. Under Karim's leadership, Noze has transitioned seamlessly from the lab to clinical applications, achieving a remarkable fivefold expansion in scale, and successfully securing over $20 million in capital. Prior to Noze, Karim established one of the first startup studios in Canada in affiliation with one of the country’s largest universities. Karim holds an MBA from Insead in France, and graduated from Concordia University in Montreal with a degree in Finance.

• 

  Chief Executive Officer (CEO) in Noze

  Disease detection through smell?